Germany Indefinitely Suspends AstraZeneca Vaccine for Anyone Under Age 60

Germany indefinitely suspended use of the Oxford-AstraZeneca COVID vaccine for  anyone under 60 following advice from STIKO, the country’s independent vaccine committee and external experts. The committee investigated reports of blood clots, some fatal, in people who received the vaccine.

According to the Associated Press, Health Minister Jens Spahn and state officials unanimously agreed to give the vaccine only to people 60 or older unless they belong to a high-risk category where the benefits outweigh the risk of a serious side-effect.

“In sum, it’s about weighing the risk of a side effect that is statistically small, but needs to be taken seriously, and the risk of falling ill with corona,” Spahn told reporters in Berlin.Ask Congress to Investigate COVID Origins – Take Action

The European Medicines Agency (EMA) today said they’ve not yet identified any risk factors — such as age, sex or a previous history of blood clotting disorders — associated with the AstraZeneca vaccine.

The EMA issued a new statement reiterating their previous conclusion that the vaccine’s benefits outweigh the risks, but cautioned that people should be aware of the “remote possibility” of rare blood clots occurring, and must seek immediate medical attention in case of symptoms.

The EMA said it “continues to work with the national authorities in the EU Member States to ensure that suspected cases of unusual blood clots are reported” and analyzed.

As The Defender reported Tuesday, several regions of Germany, including Berlin and Munich, temporarily paused the vaccine for people under 60 after Germany’s vaccine regulator disclosed 31 cases of a rare brain blood clot, nine of which resulted in deaths. The decision was made as a precaution ahead of a meeting with national medical regulators scheduled for later in the day yesterday.

The outcome of the Tuesday meeting in Germany was the decision, announced today, to indefinitely suspend use of the AstraZeneca vaccine in people under 60.

The German regulators’ decision was “based on the currently available data on the occurrence of rare but very severe thromboembolic side effects. This side effect occurred four to 16 days after vaccination, predominantly in people [under] 60 years of age,” STIKO said.

STIKO is also looking into the possibility of administering a second shot with a different COVID vaccine, for those who have already received their first dose.

Chancellor Angela Merkel said the suspension of the vaccine’s use in the under-60s would help boost citizens’ trust in AstraZeneca’s COVID vaccine after a series of missteps, Reuters reported.

“Everything is based on one principle and that is trust,” Merkel said. “Confidence arises from the knowledge that every suspicion is counted in every individual case.”

Read more…

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: